Taipei Medical University (TMU) has been a leader in Taiwan’s healthcare system since its establishment in 1960. Through its 11 colleges and 6 affiliated hospitals, TMU works with prestigious institutions from around the world to contribute to the advancement of education programs, healthcare provision, and translational research.
TMU leads in many research areas including cancer translational medicine, neuroscience, pulmonary medicine, AI in medicine, cell therapy & immunotherapy, and medical device development. With its research strengths and results being recognized by the government and funding agencies, TMU has already secured several major research grants in these areas. Moreover, TMU has helped incubate 21 startups and raised an Entrepreneurship Fund that offers support to accelerate the commercialization of research findings along with the establishment of TMU Biomed Accelerator. Finally, the imminent launch of TMU Biotech Park in Shuang Ho Campus will complete the ecosystem to support TMU’s innovative entrepreneurship. TMU’s education offers have expanded with the university’s devotion to health service worldwide, accommodating the interests of students from around the globe to develop area expertise and service their own communities.
TMU's commitment to internationalization has resulted in over 45,000 alumni working to improve healthcare systems around the world. In 2022, TMU continues to contribute to the advancement of sciences and healthcare, making a positive social impact on our communities and society.